Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Comparative effectiveness of antihypertensive drugs in patients with diabetes.

Wu HY, Hung KY, Tu YK, Chien KL.

J Comp Eff Res. 2014 May;3(3):213-5. doi: 10.2217/cer.14.10. No abstract available.

2.

Renoprotective effects of renin-angiotensin-aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis.

Catalá-López F.

Diabetologia. 2012 Sep;55(9):2547-8; author reply 2549-50. doi: 10.1007/s00125-012-2619-9. Epub 2012 Jun 23. No abstract available.

PMID:
22729654
3.

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.

Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL.

BMJ. 2013 Oct 24;347:f6008. doi: 10.1136/bmj.f6008. Review.

4.

Antihypertensive treatment of patients with diabetes and hypertension.

Julius S, Majahalme S, Palatini P.

Am J Hypertens. 2001 Nov;14(11 Pt 2):310S-316S. Review.

PMID:
11721889
5.

[Hypertension in patients with cardiac hypertrophy].

Kohno M.

Nihon Rinsho. 2004 Mar;62 Suppl 3:471-7. Review. Japanese. No abstract available.

PMID:
15171418
6.

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.

McMurray JJ, Califf RM, Bethel AM, Haffner SM, Holman RR.

J Clin Hypertens (Greenwich). 2012 Oct;14(10):731. doi: 10.1111/j.1751-7176.2012.00687.x. Epub 2012 Jul 26. No abstract available.

7.

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension.

Ritter JM.

BMJ. 2011 Apr 7;342:d1673. doi: 10.1136/bmj.d1673. No abstract available.

PMID:
21474511
8.

Use of antihypertensive medications in patients with type -2 diabetes in Ajman, UAE.

Arifulla M, John LJ, Sreedharan J, Muttappallymyalil J, Cheriathu J, Altaf Basha S.

Acta Med Iran. 2015;53(2):129-33.

9.

Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.

Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J.

Diabetologia. 2012 Mar;55(3):566-78. doi: 10.1007/s00125-011-2398-8. Epub 2011 Dec 22. Review.

10.

Antihypertensive treatments for adults with type 2 diabetes.

Majumdar SR.

BMJ. 2016 Feb 11;352:i560. doi: 10.1136/bmj.i560. No abstract available.

PMID:
26867645
11.

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.

Tazkarji B, Ganeshamoorthy A, Auten B.

Am Fam Physician. 2015 Feb 1;91(3):193-4. No abstract available.

12.

Treatment of hypertension in diabetes mellitus.

de La Sierra A, Ruilope LM.

Curr Hypertens Rep. 2000 Jun;2(3):335-42. Review.

PMID:
10981168
13.

Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?

Komers R, Anderson S.

Curr Opin Nephrol Hypertens. 2000 Mar;9(2):173-9. Review.

PMID:
10757223
14.

The impact of antihypertensive therapy in type 2 diabetes.

Hansson L.

Diabetes Obes Metab. 2000 Mar;2 Suppl 1:S37-41. Review. No abstract available.

PMID:
11225758
15.

[Hypertension and diabetes].

Bouhanick B, Laboureau-Soares Barbosa S, Marre M.

Arch Mal Coeur Vaiss. 2000 Nov;93(11 Suppl):1429-34. French.

PMID:
11190292
16.

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

Parving HH, Rossing P.

Diabetes Care. 2001 Jan;24(1):177-80. No abstract available.

PMID:
11194230
17.

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

Sofat R, Casas JP, Grosso AM, Prichard BN, Smeeth L, MacAllister R, Hingorani AD.

BMJ. 2012 Jan 13;344:d8078. doi: 10.1136/bmj.d8078. No abstract available.

18.

The role of angiotensin receptor blockers in diabetic nephropathy.

Sharma AM, Weir MR.

Postgrad Med. 2011 May;123(3):109-21. doi: 10.3810/pgm.2011.05.2289. Review.

PMID:
21566421
19.

[Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].

Higashiura K.

Nihon Rinsho. 2004 Mar;62 Suppl 3:623-7. Review. Japanese. No abstract available.

PMID:
15171446
20.

Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.

Derosa G, Maffioli P.

Expert Rev Cardiovasc Ther. 2013 Jun;11(6):719-28. doi: 10.1586/erc.13.36. Review.

PMID:
23750681
Items per page

Supplemental Content

Write to the Help Desk